Table 2 Summary of outcome measures
Outcomes (Intermediate outcome) | Interviewees | Assessment scale | Month 0 (Baseline) | Month 6 (Intermediate) | Month 12 (Endline) |
|---|---|---|---|---|---|
Primary outcome | |||||
Intermediate outcome | |||||
Symptoms of schizophrenia | Participants | Positive and Negative Syndrome Scale (PANSS) | √ | √ | √ |
Personal and social function | Participants | Personal and Social Performance Scale (PSP) | √ | √ | √ |
Antipsychotic adherence | Participants | Medication Adherence Rating Scale (MARS) | √ | √ | √ |
Knowledge of illness | Participants & primary caregiver | the Knowledge About Schizophrenia Test (KAST) | √ | √ | √ |
Hospital readmission | Participants | Electronic medical records | √ | √ | √ |
Long-term outcomes | |||||
Physical function | Participants | Activity of Daily Living Scale (ADL) & Instrumental Activity of Daily Living Scale (IADL) | √ | √ | |
Social support | Participants | Perceived Social Support Scale (PSSS) | √ | √ | |
Quality of life | Participants | the EuroQoL five-dimensional instrument (EQ-5D) & the Schizophrenia Quality of Life Scale (SQLS) | √ | √ | |
The family burden of caring | Primary caregiver | Burden Assessment Scale for families of the seriously mentally ill (BAS) | √ | √ | |
Secondary outcome Cost of illness | Participants/ Primary caregivers | Electronic medical records & self-reported self-medication cost, loss of wages of caregiver, fees of transportation, accommodation, and meals due to accompanying and care and other cost during the inpatient and outpatient service utilization | √ | √ | √ |